Taking a leave of absence, Ampio Pharmaceuticals CEO passes baton to a new board member; Axel Hoos' cancer biotech lands a CFO
Before you dive into your Thanksgiving feasts, Peer Review has some appointments to share:
→ Mike Macaluso will be taking a one-year medical leave of absence from his duties as chairman and CEO of Englewood, CO-based Ampio Pharmaceuticals after disclosing last month that he is undergoing treatment. Michael Martino took a seat at the board of directors at the time of that October announcement, and the company will now be entrusted to him as interim chairman and CEO while Macaluso is away. Ampio also revealed a month ago that COO Holli Cherevka was elevated to president and COO, while Howard Levy — a CSL Behring and Novo Nordisk vet who retired from Catalyst Biosciences this summer — was named CMO. Dicerna chairman Kevin Buchi has also been added to Ampio’s board of directors.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters